Back to Top Skip to main content Skip to sub-navigation

Adirim, Place laud DHA response to COVID-19 in briefing

Image of Defense Health Agency Director Lt. Gen. (Dr.) Ronald J. Place speaking at a press conference. Defense Health Agency Director Lt. Gen. (Dr.) Ronald J. Place said in Thursday’s press conference that he hosted a meeting with allies and partner nations' medical communities to better understand effective approaches to COVID-19 (Frame grab from Defense.gov video).

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus

Dr. Terry Adirim, acting assistant secretary of defense for health affairs, and Army Lt. Gen. (Dr.) Ronald J. Place, director of the Defense Health Agency, provided a COVID-19 update Thursday during a Pentagon press briefing. Read full transcript.

Just one month ago, when vaccinations were available to everyone, the active duty population was only at 37% receiving one dose, said Adirim. "So, we're making good, steady progress."

It's important to note that COVID-19 infection incidents for DOD personnel are lower than for the civilian population, she said. "That is a sign that our force health protection measures are working."

The department has redoubled its efforts to encourage everyone to get vaccinated, she noted.

Last week, in accordance with the Centers for Disease Control and Prevention guidance on masking, the department announced that fully vaccinated personnel can safely participate in most activities and are no longer required to wear a mask indoors or outdoors at most DOD facilities, she said. However, unvaccinated personnel should continue wearing masks as required by DOD policy to protect themselves and others who have not been fully vaccinated.

Defense Department service members, including the National Guard, have so far administered over 15 million doses of vaccines to civilians across America, she added.

Place said that last week when the Food and Drug Administration authorized the Pfizer vaccine for 12- to 15-year-olds, DOD began shipping it overseas for DOD's adolescent community.

Earlier this week, Place said he hosted a meeting with allies and partner nations' medical communities to better understand effective approaches in terms of both treatment and vaccinations.

"I'm grateful for the contributions and collaboration of so many medical professionals throughout the United States and across the world," he said.

You also may be interested in...

20-004

Policy

Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

DHA-Policy Memorandum 21-004: Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

6205.01

Policy

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

3020.01, Change 2

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

3020.01, Change 1

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

  • Identification #: 20-003
  • Date: 5/13/2020
  • Type: Memorandums
  • Topics: Coronavirus
Showing results 1 - 12 Page 1 of 1
Refine your search
Last Updated: May 21, 2021

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.